S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:DSRLF

DiaSorin (DSRLF) Stock Price, News & Analysis

$92.22
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$92.22
$92.22
50-Day Range
$92.22
$98.56
52-Week Range
$86.00
$120.00
Volume
N/A
Average Volume
N/A
Market Capitalization
$5.05 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DSRLF stock logo

About DiaSorin Stock (OTCMKTS:DSRLF)

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

DSRLF Stock Price History

DSRLF Stock News Headlines

Diasorin SpA DIA
DiaSorin S.p.A. reports 1H results
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
DiaSorin S.p.A.
DiaSorin: Overvalued Italian Healthcare Company
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
See More Headlines
Receive DSRLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:DSRLF
CIK
N/A
Fax
N/A
Employees
3,386
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.43 billion
Cash Flow
$9.09 per share
Book Value
$29.27 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.05 billion
Optionable
Not Optionable
Beta
0.29
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Carlo Rosa (Age 58)
    CEO, GM & Executive Director
    Comp: $1.9M
  • Dr. Chen Menachem Even (Age 61)
    Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director
    Comp: $930.98k
  • Mr. Piergiorgio Pedron (Age 53)
    Senior Corporate VP, CFO & Corporate Accounting Documents Officer
  • Mr. Fabrizio Piercarlo Bonelli
    Corporate VP & Chief Technology Officer
  • Dr. Riccardo Fava
    Corporate Vice President of Communication & Investor Relations
  • Mr. Ulisse Spada
    Corporate VP, Head of the Legal Department, Secretary & General Counsel
  • Mr. Stefano Ronchi (Age 64)
    Senior Corporate Vice President of Human Resources
  • Mr. Ugo Gay (Age 59)
    Chief Executive Officer of DiaSorin Italia S.p.A.
  • Mr. Angelo Rago (Age 61)
    President of Luminex Corporation

DSRLF Stock Analysis - Frequently Asked Questions

Should I buy or sell DiaSorin stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DiaSorin in the last twelve months. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" DSRLF shares.
View DSRLF analyst ratings
or view top-rated stocks.

How have DSRLF shares performed in 2024?

DiaSorin's stock was trading at $99.7828 on January 1st, 2024. Since then, DSRLF shares have decreased by 7.6% and is now trading at $92.22.
View the best growth stocks for 2024 here
.

Are investors shorting DiaSorin?

DiaSorin saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 483,400 shares, an increase of 9.3% from the February 29th total of 442,100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.
View DiaSorin's Short Interest
.

How do I buy shares of DiaSorin?

Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DSRLF) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners